
### ü´† Aortic Syndromes: Penetrating Aortic Ulcer (Type B)

#### ‚úÖ True Statements
1. **Type B acute aortic syndromes** originate distal to the **left subclavian artery** and include **aortic dissection**, **penetrating aortic ulcers**, and **intramural aortic hematomas**.
2. **Penetrating aortic ulcer** is defined as **ulceration at an atheromatous plaque site** that extends through the **aortic intima** into the **aortic media**.
3. Most patients with **stable type B acute aortic syndromes** can be managed medically with **intravenous Œ≤-blockers**, **aggressive blood pressure control**, **pain management**, **statins**, and **active surveillance**.
4. **Intravenous Œ≤-blockers** are first-line therapy in acute aortic syndromes, with a goal of reducing **systolic blood pressure to ‚â§120 mm Hg** within the **first hour**.
5. If systolic blood pressure is not controlled after Œ≤-blocker initiation, **intravenous vasodilators** such as **nitroprusside** or **nicardipine** may be added.
6. **Pain control** in acute aortic syndromes is best achieved with **intravenous opioids**.
7. **Vasodilators** like nitroprusside should only be started **after Œ≤-blocker therapy**, as vasodilators alone can increase **shear stress in the aorta**.
8. **Open surgical aortic repair** is not indicated in **hemodynamically stable** patients with **type B aortic syndrome**, due to its associated **morbidity and mortality**, especially in older patients with **comorbidities**.
9. **Reimaging within 48 hours** is not the initial step in management; it should be performed **only if clinical status changes**.

#### üí¨ Extra
1. The descending thoracic aorta begins distal to the left subclavian artery.
3. Medical management is preferred in stable type B disease to reduce procedural risk.
4. Rapid blood pressure reduction lowers the risk of propagation or rupture.
7. Œ≤-Blockers blunt the reflex sympathetic activation and heart rate rise caused by vasodilators.
8. Surgery is reserved for complications like malperfusion, rupture, or refractory symptoms.
9. Initial therapy should prioritize blood pressure stabilization before repeat imaging is considered.

#### üî∑ Tags
#Cardiology #EmergentCare #PatientOver65 #AorticSyndrome #PenetratingAorticUlcer #BetaBlocker #BloodPressureManagement

#### üìô Reference
Sorber R, Hicks CW. Diagnosis and management of acute aortic syndromes: dissection, penetrating aortic ulcer, and intramural hematoma. *Curr Cardiol Rep*. 2022;24:209-216. PMID: 35029783 doi:10.1007/s11886-022-01642-3

#### üÜî Question ID
CVMCQ24052

#### üïí Last Updated
January 2025

---

#### üìñ Related Text
MKSAP 19: Cardiovascular Medicine ‚Äî Diseases of the Aorta, Acute Aortic Syndromes, Treatment of Acute Aortic Syndromes

---

### üìò Related Text Derivations

#### ‚úÖ True Statements
1. Patients with **acute aortic dissection without shock** should be treated in a **critical care setting** with **heart rate and blood pressure reduction**.
2. Guidelines recommend reducing **systolic blood pressure to ‚â§120 mm Hg** within **1 hour** for acute aortic dissection.
3. **Intravenous Œ≤-blockers** are the **first-line therapy** for acute aortic dissection.
4. If hypertension is not controlled with Œ≤-blockers, **intravenous vasodilators** (e.g., **nitroprusside**, **nicardipine**) should be added.
5. **Pain management** with **intravenous opioids** is essential in treating acute aortic syndromes.
6. **Uncomplicated type B acute aortic syndromes** are usually treated with **medical therapy alone**.
7. In **type B aortic dissection**, presence of **refractory chest pain**, **hypertension**, **rapid aortic expansion**, or **organ malperfusion** indicates need for **aortic repair**, typically with **thoracic endovascular aortic repair (TEVAR)**.
8. In **type A penetrating atherosclerotic ulcers or intramural hematomas**, or those with **aortic enlargement or progression**, **immediate aortic repair** is indicated.

#### üí¨ Extra
1. Critical care allows for close hemodynamic monitoring and rapid escalation if needed.
2. Early aggressive blood pressure control reduces risk of progression or rupture.
4. Vasodilators reduce afterload but should not be used alone initially due to risk of increased shear force.
6. Stable cases benefit from lower-risk medical strategies.
7. TEVAR improves aortic-specific outcomes at 5 years but is reserved for complications or progression.
8. Type A lesions pose higher risk and typically require urgent surgical intervention.

#### üî∑ Tags
#AorticDissection #TEVAR #IntramuralHematoma #AorticUlcer #CriticalCare #Opioids #Vasodilators #GuidelineDirectedTherapy

---

#### üñºÔ∏è Supplemental Figures

<figure>
  <img src="Acute Surgical Management Pathway for Type A Aortic Dissection.svg" alt="Acute Surgical Management Pathway for Type A Aortic Dissection">
  <figcaption>
    <strong>Acute Surgical Management Pathway for Type A Aortic Dissection</strong><br>
    AoD = aortic dissection; CABG = coronary artery bypass grafting; CAD = coronary artery disease; TEE = transesophageal echocardiography.<br>
    <sup>a</sup>Addition of ‚Äúif appropriate‚Äù based on Patel MR, Dehmer GJ, Hirshfeld JW, et al. J Am Coll Cardiol. 2009;53:530-53. PMID: 19195618 doi:10.1016/j.jacc.2008.10.005<br>
    Reprinted from Hiratzka LF, Bakris GL, Beckman JA, et al. J Am Coll Cardiol. 2010;55:e27-e129. PMID: 20359588 doi:10.1016/j.jacc.2010.02.015. ¬©2010, with permission from American College of Cardiology Foundation and the American Heart Association, Inc.
  </figcaption>
</figure>
